As regulatory reform continues to evolve in the US and Europe, the role of regulatory affairs is poised to help shape the more personalized treatment landscape on the horizon.
Stef Schutte, PharmD, MSc
Advertisement
EVP, head of regulatory affairs, Astellas Pharma Inc.
Articles by Stef Schutte, PharmD, MSc
Advertisement
Latest Updated Articles
How Regulatory Affairs Is Shaping Tomorrow’s Innovation LandscapePublished: April 26th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist
2
Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody
3
Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
4
Rethinking Tail Spend: Transforming Procurement Before Compliance Risks Escalate
5